{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T07:01:22Z","timestamp":1781247682126,"version":"3.54.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771167"],"award-info":[{"award-number":["81771167"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870840"],"award-info":[{"award-number":["81870840"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s12035-020-02174-z","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T07:02:52Z","timestamp":1603436572000},"page":"1114-1127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prostaglandin A1 Decreases the Phosphorylation of Tau by Activating Protein Phosphatase 2A via a Michael Addition Mechanism at Cysteine 377"],"prefix":"10.1007","volume":"58","author":[{"given":"Guo-Biao","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Pei","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9617-5686","authenticated-orcid":false,"given":"Pu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"issue":"7","key":"2174_CR1","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jamaneurol.2016.0301","volume":"73","author":"RN Rosenberg","year":"2016","unstructured":"Rosenberg RN, Lambracht-Washington D, Yu G, Xia W (2016) Genomics of Alzheimer disease: a review. JAMA Neurol 73(7):867\u2013874","journal-title":"JAMA Neurol"},{"issue":"10","key":"2174_CR2","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.bpj.2013.09.045","volume":"105","author":"C Poojari","year":"2013","unstructured":"Poojari C, Xiao D, Batista VS, Strodel B (2013) Membrane permeation induced by aggregates of human islet amyloid polypeptides. Biophys J 105(10):2323\u20132332","journal-title":"Biophys J"},{"issue":"12","key":"2174_CR3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1474-4422(05)70248-9","volume":"4","author":"LA Shobab","year":"2005","unstructured":"Shobab LA, Hsiung GY, Feldman HH (2005) Cholesterol in Alzheimer\u2019s disease. Lancet Neurol 4(12):841\u2013852","journal-title":"Lancet Neurol"},{"issue":"3","key":"2174_CR4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2337\/diabetes.53.3.795","volume":"53","author":"N Shanmugam","year":"2004","unstructured":"Shanmugam N, Gaw Gonzalo IT, Natarajan R (2004) Molecular mechanisms of high glucose-induced cyclooxygenase-2 expression in monocytes. Diabetes 53(3):795\u2013802","journal-title":"Diabetes"},{"issue":"3, Supplement 1","key":"2174_CR5","doi-asserted-by":"crossref","first-page":"605a","DOI":"10.1016\/j.bpj.2008.12.3199","volume":"96","author":"W Zhu","year":"2009","unstructured":"Zhu W, Olsher M, Venegas B, Tran S, Chong PLG (2009) Role Of membrane cholesterol content in the activity of cyclooxygenase-2 (COX-2) in MCF-7 human breast cancer cells. Biophys J 96(3, Supplement 1):605a","journal-title":"Biophys J"},{"issue":"1","key":"2174_CR6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1096\/fj.201800355RRRR","volume":"33","author":"PP Guan","year":"2019","unstructured":"Guan PP, Wang P (2019) Integrated communications between cyclooxygenase-2 and Alzheimer\u2019s disease. FASEB J 33(1):13\u201333","journal-title":"FASEB J"},{"issue":"4","key":"2174_CR7","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/acel.12209","volume":"13","author":"P Wang","year":"2014","unstructured":"Wang P, Guan PP, Wang T, Yu X, Guo JJ, Wang ZY (2014) Aggravation of Alzheimer\u2019s disease due to the COX-2-mediated reciprocal regulation of IL-1beta and Abeta between glial and neuron cells. Aging Cell 13(4):605\u2013615","journal-title":"Aging Cell"},{"key":"2174_CR8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biomaterials.2017.07.023","volume":"145","author":"JW Guo","year":"2017","unstructured":"Guo JW, Guan PP, Ding WY, Wang SL, Huang XS, Wang ZY, Wang P (2017) Erythrocyte membrane-encapsulated celecoxib improves the cognitive decline of Alzheimer\u2019s disease by concurrently inducing neurogenesis and reducing apoptosis in APP\/PS1 transgenic mice. Biomaterials 145:106\u2013127","journal-title":"Biomaterials"},{"issue":"4","key":"2174_CR9","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s13311-019-00770-z","volume":"16","author":"P-P Guan","year":"2019","unstructured":"Guan P-P, Liang Y-Y, Cao L-L, Yu X, Wang P (2019) Cyclooxygenase-2 induced the \u03b2-amyloid protein deposition and neuronal apoptosis via upregulating the synthesis of prostaglandin E2 and 15-Deoxy-\u25b312,14-prostaglandin J2. Neurotherapeutics 16(4):1255\u20131268","journal-title":"Neurotherapeutics"},{"key":"2174_CR10","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.18632\/aging.101615","volume":"10","author":"C Lu","year":"2018","unstructured":"Lu C, Ma J, Luo Z, Tai Q, Wang P (2018) Transferrin is responsible for mediating the effects of iron ions on the regulation of anterior pharynx-defective-1\u03b1\/\u03b2 and presenilin 1 expression via PGE2 and PGD2 at the early stage of Alzheimer\u2019s disease. Aging 10:3117\u20133135","journal-title":"Aging"},{"issue":"5","key":"2174_CR11","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/acel.12495","volume":"15","author":"P Wang","year":"2016","unstructured":"Wang P, Guan PP, Guo JW, Cao LL, Xu GB, Yu X, Wang Y, Wang ZY (2016) Prostaglandin I2 upregulates the expression of anterior pharynx-defective-1\u03b1 and anterior pharynx-defective-1\u03b2 in amyloid precursor protein\/presenilin 1 transgenic mice. Aging Cell 15(5):861\u2013871","journal-title":"Aging Cell"},{"issue":"12","key":"2174_CR12","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.bbapap.2008.09.003","volume":"1784","author":"K Dueckershoff","year":"2008","unstructured":"Dueckershoff K, Mueller S, Mueller MJ, Reinders J (2008) Impact of cyclopentenone-oxylipins on the proteome of Arabidopsis thaliana. Biochim Biophys Acta 1784(12):1975\u20131985","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"2174_CR13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/med.1006","volume":"21","author":"DS Straus","year":"2001","unstructured":"Straus DS, Glass CK (2001) Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev 21(3):185\u2013210","journal-title":"Med Res Rev"},{"issue":"1","key":"2174_CR14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0005-2760(75)90184-8","volume":"398","author":"LM Cagen","year":"1975","unstructured":"Cagen LM, Pisano JJ, Ketley JN, Habig WH, Jakoby WB (1975) The conjugation of prostaglandin A1 and glutathione catalyzed by homogeneous glutathione S-transferases from human and rat liver. Biochim Biophys Acta Lipids Lipid Metab 398(1):205\u2013208","journal-title":"Biochim Biophys Acta Lipids Lipid Metab"},{"issue":"1","key":"2174_CR15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0006-291X(85)91398-1","volume":"129","author":"KV Honn","year":"1985","unstructured":"Honn KV, Marnett LJ (1985) Requirement of a reactive \u03b1, \u03b2-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by \u201cA\u201d series prostaglandins. Biochem Biophys Res Commun 129(1):34\u201340","journal-title":"Biochem Biophys Res Commun"},{"issue":"14","key":"2174_CR16","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.1073\/pnas.89.14.6227","volume":"89","author":"C Amici","year":"1992","unstructured":"Amici C, Sistonen L, Santoro MG, Morimoto RI (1992) Antiproliferative prostaglandins activate heat shock transcription factor. Proc Natl Acad Sci U S A 89(14):6227\u20136231","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2174_CR17","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1073\/pnas.94.2.746","volume":"94","author":"A Rossi","year":"1997","unstructured":"Rossi A, Elia G, Santoro MG (1997) Inhibition of nuclear factor \u03baB by prostaglandin A1: an effect associated with heat shock transcription factor activation. Proc Natl Acad Sci U S A 94(2):746\u2013750","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2174_CR18","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1158\/0008-5472.CAN-10-3816","volume":"71","author":"B D\u00edez Dacal","year":"2011","unstructured":"D\u00edez Dacal B, Gayarre J, Gharbi S, Timms JF, Coderch C, Gago F et al (2011) Identification of aldo-keto reductase AKR1B10 as a selective target for modification and inhibition by prostaglandin A1: implications for antitumoral activity. Cancer Res 71(12):4161\u20134171","journal-title":"Cancer Res"},{"issue":"1","key":"2174_CR19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1196\/annals.1397.072","volume":"1096","author":"J Gayarre","year":"2007","unstructured":"Gayarre J, Isabel Avellano M, S\u00e1nchez G\u00f3mez FJ, Carrasco MJ, Ca\u00f1ada FJ, P\u00e9rez Sala D (2007) Modification of proteins by cyclopentenone prostaglandins is differentially modulated by GSH in vitro. Ann N Y Acad Sci 1096(1):78\u201385","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"2174_CR20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1749-6632.2002.tb04695.x","volume":"973","author":"D P\u00e9rez Sala","year":"2002","unstructured":"P\u00e9rez Sala D, Cernuda Moroll\u00f3n E, Pineda Molina E, Ca\u00f1ada FJ (2002) Contribution of covalent protein modification to the antiinflammatory effects of cyclopentenone prostaglandins. Ann N Y Acad Sci 973(1):533\u2013536","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"2174_CR21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/mas.21383","volume":"33","author":"CL Oeste","year":"2014","unstructured":"Oeste CL, P\u00e9rez Sala D (2014) Modification of cysteine residues by cyclopentenone prostaglandins: interplay with redox regulation of protein function. Mass Spectrom Rev 33(2):110\u2013125","journal-title":"Mass Spectrom Rev"},{"issue":"1","key":"2174_CR22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brainres.2006.04.111","volume":"1102","author":"XH Xu","year":"2006","unstructured":"Xu XH, Zhang HL, Han R, Gu ZL, Qin ZH (2006) Enhancement of neuroprotection and heat shock protein induction by combined prostaglandin A1 and lithium in rodent models of focal ischemia. Brain Res 1102(1):154\u2013162","journal-title":"Brain Res"},{"issue":"5","key":"2174_CR23","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1046\/j.1471-4159.2002.01224.x","volume":"83","author":"X Wang","year":"2002","unstructured":"Wang X, Qin ZH, Leng Y, Wang Y, Jin X, Chase TN, Bennett MC (2002) Prostaglandin A1 inhibits rotenone-induced apoptosis in SH-SY5Y cells. J Neurochem 83(5):1094\u20131102","journal-title":"J Neurochem"},{"issue":"1","key":"2174_CR24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1128\/JB.184.1.91-103.2002","volume":"184","author":"JW Seo","year":"2002","unstructured":"Seo JW, Ohnishi Y, Hirata A, Horinouchi S (2002) ATP-binding cassette transport system involved in regulation of morphological differentiation in response to glucose in Streptomyces griseus. J Bacteriol 184(1):91\u2013103","journal-title":"J Bacteriol"},{"issue":"2","key":"2174_CR25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s13311-018-00704-1","volume":"16","author":"GB Xu","year":"2019","unstructured":"Xu GB, Yang LQ, Guan PP, Wang ZY, Wang P (2019) Prostaglandin A1 inhibits the cognitive decline of APP\/PS1 transgenic mice via PPARgamma\/ABCA1-dependent cholesterol efflux mechanisms. Neurotherapeutics 16(2):505\u2013522","journal-title":"Neurotherapeutics"},{"issue":"2","key":"2174_CR26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2174\/156720512799361682","volume":"9","author":"L Torrent","year":"2012","unstructured":"Torrent L, Ferrer I (2012) PP2A and Alzheimer disease. Curr Alzheimer Res 9(2):248\u2013256","journal-title":"Curr Alzheimer Res"},{"key":"2174_CR27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pharmthera.2019.05.016","volume":"201","author":"AR Clark","year":"2019","unstructured":"Clark AR, Ohlmeyer M (2019) Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration. Pharmacol Ther 201:181\u2013201","journal-title":"Pharmacol Ther"},{"issue":"1","key":"2174_CR28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.arr.2012.06.008","volume":"12","author":"L Martin","year":"2013","unstructured":"Martin L, Latypova X, Wilson CM, Magnaudeix A, Perrin ML, Terro F (2013) Tau protein phosphatases in Alzheimer\u2019s disease: the leading role of PP2A. Ageing Res Rev 12(1):39\u201349","journal-title":"Ageing Res Rev"},{"issue":"2","key":"2174_CR29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3940(03)00096-X","volume":"340","author":"CX Gong","year":"2003","unstructured":"Gong CX, Wang JZ, Iqbal K, Grundke-Iqbal I (2003) Inhibition of protein phosphatase 2A induces phosphorylation and accumulation of neurofilaments in metabolically active rat brain slices. Neurosci Lett 340(2):107\u2013110","journal-title":"Neurosci Lett"},{"key":"2174_CR30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neuro.2013.05.002","volume":"37","author":"PK Kamat","year":"2013","unstructured":"Kamat PK, Rai S, Nath C (2013) Okadaic acid induced neurotoxicity: an emerging tool to study Alzheimer\u2019s disease pathology. Neurotoxicology 37:163\u2013172","journal-title":"Neurotoxicology"},{"issue":"2","key":"2174_CR31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3233\/JAD-142403","volume":"45","author":"X Wang","year":"2015","unstructured":"Wang X, Blanchard J, Tung YC, Grundke-Iqbal I, Iqbal K (2015) Inhibition of protein phosphatase-2A (PP2A) by I1PP2A leads to hyperphosphorylation of tau, neurodegeneration, and cognitive impairment in rats. J Alzheimers Dis 45(2):423\u2013435","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"2174_CR32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neurobiolaging.2012.04.007","volume":"34","author":"J Morales-Corraliza","year":"2013","unstructured":"Morales-Corraliza J, Schmidt SD, Mazzella MJ, Berger JD, Wilson DA, Wesson DW, Jucker M, Levy E et al (2013) Immunization targeting a minor plaque constituent clears beta-amyloid and rescues behavioral deficits in an Alzheimer\u2019s disease mouse model. Neurobiol Aging 34(1):137\u2013145","journal-title":"Neurobiol Aging"},{"key":"2174_CR33","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1186\/1756-0500-7-671","volume":"7","author":"AL Larentis","year":"2014","unstructured":"Larentis AL, Nicolau JF, Esteves Gdos S, Vareschini DT, de Almeida FV, dos Reis MG et al (2014) Evaluation of pre-induction temperature, cell growth at induction and IPTG concentration on the expression of a leptospiral protein in E. coli using shaking flasks and microbioreactor. BMC Res Notes 7:671","journal-title":"BMC Res Notes"},{"issue":"25","key":"2174_CR34","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1016\/j.febslet.2005.09.069","volume":"579","author":"J Gayarre","year":"2005","unstructured":"Gayarre J, Stamatakis K, Renedo M, P\u00e9rez-Sala D (2005) Differential selectivity of protein modification by the cyclopentenone prostaglandins PGA1 and 15-deoxy-\u039412, 14-PGJ2: role of glutathione. FEBS Lett 579(25):5803\u20135808","journal-title":"FEBS Lett"},{"issue":"5","key":"2174_CR35","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1124\/mol.104.002824","volume":"66","author":"FJ Sanchez Gomez","year":"2004","unstructured":"Sanchez Gomez FJ, Cernuda Morollon E, Stamatakis K, Perez SD (2004) Protein thiol modification by 15-deoxy-\u039412, 14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes. Mol Pharmacol 66(5):1349\u20131358","journal-title":"Mol Pharmacol"},{"issue":"2","key":"2174_CR36","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.molcel.2018.03.006","volume":"70","author":"WW Gao","year":"2018","unstructured":"Gao WW, Xiao RQ, Zhang WJ, Hu YR, Peng BL, Li WJ, He YH, Shen HF et al (2018) JMJD6 licenses ERalpha-dependent enhancer and coding gene activation by modulating the recruitment of the CARM1\/MED12 co-activator complex. Mol Cell 70(2):340\u201357 e8","journal-title":"Mol Cell"},{"issue":"11","key":"2174_CR37","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/jms.1291","volume":"42","author":"S Gharbi","year":"2007","unstructured":"Gharbi S, Garzon B, Gayarre J, Timms J, Perez-Sala D (2007) Study of protein targets for covalent modification by the antitumoral and anti-inflammatory prostaglandin PGA1: focus on vimentin. J Mass Spectrom 42(11):1474\u20131484","journal-title":"J Mass Spectrom"},{"issue":"1\u20132","key":"2174_CR38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-5793(00)01738-5","volume":"477","author":"E Mossner","year":"2000","unstructured":"Mossner E, Iwai H, Glockshuber R (2000) Influence of the pK(a) value of the buried, active-site cysteine on the redox properties of thioredoxin-like oxidoreductases. FEBS Lett 477(1\u20132):21\u201326","journal-title":"FEBS Lett"},{"issue":"7","key":"2174_CR39","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/1873-3468.12907","volume":"592","author":"G Taleski","year":"2018","unstructured":"Taleski G, Sontag E (2018) Protein phosphatase 2A and tau: an orchestrated \u2018Pas de Deux\u2019. FEBS Lett 592(7):1079\u20131095","journal-title":"FEBS Lett"},{"issue":"12","key":"2174_CR40","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1101\/gr.6.12.1207","volume":"6","author":"MM Sarwal","year":"1996","unstructured":"Sarwal MM, Sontag JM, Hoang L, Brenner S, Wilkie TM (1996) G protein alpha subunit multigene family in the Japanese puffer fish Fugu rubripes: PCR from a compact vertebrate genome. Genome Res 6(12):1207\u20131215","journal-title":"Genome Res"},{"key":"2174_CR41","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.conb.2015.09.004","volume":"36","author":"L Kruger","year":"2016","unstructured":"Kruger L, Mandelkow EM (2016) Tau neurotoxicity and rescue in animal models of human Tauopathies. Curr Opin Neurobiol 36:52\u201358","journal-title":"Curr Opin Neurobiol"},{"issue":"3","key":"2174_CR42","doi-asserted-by":"crossref","first-page":"226","DOI":"10.5114\/fn.2015.54423","volume":"53","author":"K Wang","year":"2015","unstructured":"Wang K, Xie M, Zhu L, Zhu X, Zhang K, Zhou F (2015) Ciliary neurotrophic factor protects SH-SY5Y neuroblastoma cells against Abeta1-42-induced neurotoxicity via activating the JAK2\/STAT3 axis. Folia Neuropathol 53(3):226\u2013235","journal-title":"Folia Neuropathol"},{"issue":"5","key":"2174_CR43","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1745-7254.2006.00311.x","volume":"27","author":"Y Zhu","year":"2006","unstructured":"Zhu Y, Gu ZL, Liang ZQ, Zhang HL, Qin ZH (2006) Prostaglandin A1 inhibits increases in intracellular calcium concentration, TXA(2) production and platelet activation. Acta Pharmacol Sin 27(5):549\u2013554","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"2174_CR44","first-page":"78","volume":"297","author":"ZH Qin","year":"2001","unstructured":"Qin ZH, Wang Y, Chen RW, Wang X, Ren M, Chuang DM, Chase TN (2001) Prostaglandin A(1) protects striatal neurons against excitotoxic injury in rat striatum. J Pharmacol Exp Ther 297(1):78\u201387","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"2174_CR45","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/jnr.21569","volume":"86","author":"HL Zhang","year":"2008","unstructured":"Zhang HL, Gu ZL, Savitz SI, Han F, Fukunaga K, Qin ZH (2008) Neuroprotective effects of prostaglandin A(1) in rat models of permanent focal cerebral ischemia are associated with nuclear factor-kappaB inhibition and peroxisome proliferator-activated receptor-gamma up-regulation. J Neurosci Res 86(5):1132\u20131141","journal-title":"J Neurosci Res"},{"key":"2174_CR46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainres.2012.09.008","volume":"1482","author":"Y Hirata","year":"2012","unstructured":"Hirata Y, Furuta K, Suzuki M, Oh-hashi K, Ueno Y, Kiuchi K (2012) Neuroprotective cyclopentenone prostaglandins up-regulate neurotrophic factors in C6 glioma cells. Brain Res 1482:91\u2013100","journal-title":"Brain Res"},{"issue":"22","key":"2174_CR47","doi-asserted-by":"crossref","first-page":"6607","DOI":"10.1021\/bi602389p","volume":"46","author":"M Renedo","year":"2007","unstructured":"Renedo M, Gayarre J, Garcia-Dominguez CA, Perez-Rodriguez A, Prieto A, Canada FJ et al (2007) Modification and activation of Ras proteins by electrophilic prostanoids with different structure are site-selective. Biochemistry 46(22):6607\u20136616","journal-title":"Biochemistry"},{"issue":"1","key":"2174_CR48","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cbi.2009.09.019","volume":"183","author":"B Garzon","year":"2010","unstructured":"Garzon B, Gayarre J, Gharbi S, Diez-Dacal B, Sanchez-Gomez FJ, Timms JF et al (2010) A biotinylated analog of the anti-proliferative prostaglandin A1 allows assessment of PPAR-independent effects and identification of novel cellular targets for covalent modification. Chem Biol Interact 183(1):212\u2013221","journal-title":"Chem Biol Interact"},{"issue":"1\u20134","key":"2174_CR49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.prostaglandins.2004.11.003","volume":"75","author":"L Gazi","year":"2005","unstructured":"Gazi L, Gyles S, Rose J, Lees S, Allan C, Xue L, Jassal R, Speight G et al (2005) Delta12-prostaglandin D2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytes. Prostaglandins Other Lipid Mediat 75(1\u20134):153\u2013167","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"5","key":"2174_CR50","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrd1383","volume":"3","author":"DW Gilroy","year":"2004","unstructured":"Gilroy DW, Lawrence T, Perretti M, Rossi AG (2004) Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 3(5):401\u2013416","journal-title":"Nat Rev Drug Discov"},{"issue":"17","key":"2174_CR51","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1158\/1078-0432.CCR-08-3101","volume":"15","author":"SW Shin","year":"2009","unstructured":"Shin SW, Seo CY, Han H, Han JY, Jeong JS, Kwak JY, Park JI (2009) 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity. Clin Cancer Res 15(17):5414\u20135425","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2174_CR52","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/187152812798889349","volume":"11","author":"AE Martinez","year":"2012","unstructured":"Martinez AE, Sanchez-Gomez FJ, Diez-Dacal B, Oeste CL, Perez-Sala D (2012) 15-Deoxy-Delta(12,14)-prostaglandin J2 exerts pro- and anti-inflammatory effects in mesangial cells in a concentration-dependent manner. Inflamm Allergy Drug Targets 11(1):58\u201365","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"11","key":"2174_CR53","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1523\/JNEUROSCI.4361-12.2013","volume":"33","author":"S Ghosh","year":"2013","unstructured":"Ghosh S, Wu MD, Shaftel SS, Kyrkanides S, LaFerla FM, Olschowka JA et al (2013) Sustained interleukin-1beta overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer\u2019s mouse model. J Neurosci 33(11):5053\u20135064","journal-title":"J Neurosci"},{"issue":"12","key":"2174_CR54","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.4049\/jimmunol.1100620","volume":"187","author":"M Kitazawa","year":"2011","unstructured":"Kitazawa M, Cheng D, Tsukamoto MR, Koike MA, Wes PD, Vasilevko V, Cribbs DH, LaFerla FM (2011) Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal beta-catenin pathway function in an Alzheimer\u2019s disease model. J Immunol 187(12):6539\u20136549","journal-title":"J Immunol"},{"issue":"3","key":"2174_CR55","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00001756-200303030-00023","volume":"14","author":"K Tanji","year":"2003","unstructured":"Tanji K, Mori F, Imaizumi T, Yoshida H, Satoh K, Wakabayashi K (2003) Interleukin-1 induces tau phosphorylation and morphological changes in cultured human astrocytes. Neuroreport. 14(3):413\u2013417","journal-title":"Neuroreport."},{"issue":"1\u20132","key":"2174_CR56","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jneuroim.2008.09.012","volume":"205","author":"JO Ojala","year":"2008","unstructured":"Ojala JO, Sutinen EM, Salminen A, Pirttila T (2008) Interleukin-18 increases expression of kinases involved in tau phosphorylation in SH-SY5Y neuroblastoma cells. J Neuroimmunol 205(1\u20132):86\u201393","journal-title":"J Neuroimmunol"},{"issue":"1","key":"2174_CR57","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yexcr.2004.01.002","volume":"295","author":"RA Quintanilla","year":"2004","unstructured":"Quintanilla RA, Orellana DI, Gonzalez-Billault C, Maccioni RB (2004) Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5\/p35 pathway. Exp Cell Res 295(1):245\u2013257","journal-title":"Exp Cell Res"},{"issue":"1\u20132","key":"2174_CR58","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0165-5728(01)00267-3","volume":"115","author":"PD Drew","year":"2001","unstructured":"Drew PD, Chavis JA (2001) The cyclopentone prostaglandin 15-deoxy-delta(12,14) prostaglandin J2 represses nitric oxide, TNF-alpha, and IL-12 production by microglial cells. J Neuroimmunol 115(1\u20132):28\u201335","journal-title":"J Neuroimmunol"},{"issue":"11","key":"2174_CR59","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.chembiol.2017.08.013","volume":"24","author":"EA Grossman","year":"2017","unstructured":"Grossman EA, Ward CC, Spradlin JN, Bateman LA, Huffman TR, Miyamoto DK, Kleinman JI, Nomura DK (2017) Covalent ligand discovery against druggable hotspots targeted by anti-cancer natural products. Cell Chem Biol 24(11):1368\u201376 e4","journal-title":"Cell Chem Biol"},{"issue":"11","key":"2174_CR60","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.chembiol.2017.10.013","volume":"24","author":"DS Johnson","year":"2017","unstructured":"Johnson DS, Majmudar JD (2017) Bond with me if you can! Natural product, covalent ligand, and reactivity-based probe compete for cysteine in PP2A complex. Cell Chem Biol 24(11):1317\u20131318","journal-title":"Cell Chem Biol"},{"key":"2174_CR61","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neurobiolaging.2019.06.008","volume":"81","author":"J Miron","year":"2019","unstructured":"Miron J, Picard C, Labonte A, Auld D, Breitner J, Poirier J (2019) Association of PPP2R1A with Alzheimer\u2019s disease and specific cognitive domains. Neurobiol Aging 81:234\u2013243","journal-title":"Neurobiol Aging"},{"issue":"4","key":"2174_CR62","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/jnen\/63.4.287","volume":"63","author":"E Sontag","year":"2004","unstructured":"Sontag E, Luangpirom A, Hladik C, Mudrak I, Ogris E, Speciale S, White CL III (2004) Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology. J Neuropathol Exp Neurol 63(4):287\u2013301","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"2174_CR63","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1471-4159.1993.tb03603.x","volume":"61","author":"CX Gong","year":"1993","unstructured":"Gong CX, Singh TJ, Grundke-Iqbal I, Iqbal K (1993) Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 61(3):921\u2013927","journal-title":"J Neurochem"},{"issue":"2","key":"2174_CR64","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/exnr.2001.7630","volume":"168","author":"V Vogelsberg-Ragaglia","year":"2001","unstructured":"Vogelsberg-Ragaglia V, Schuck T, Trojanowski JQ, Lee VM (2001) PP2A mRNA expression is quantitatively decreased in Alzheimer\u2019s disease hippocampus. Exp Neurol 168(2):402\u2013412","journal-title":"Exp Neurol"},{"issue":"2","key":"2174_CR65","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1046\/j.1471-4159.1995.65020732.x","volume":"65","author":"CX Gong","year":"1995","unstructured":"Gong CX, Shaikh S, Wang JZ, Zaidi T, Grundke-Iqbal I, Iqbal K (1995) Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J Neurochem 65(2):732\u2013738","journal-title":"J Neurochem"},{"issue":"9","key":"2174_CR66","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jinorgbio.2007.06.001","volume":"101","author":"JR Walton","year":"2007","unstructured":"Walton JR (2007) An aluminum-based rat model for Alzheimer\u2019s disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration. J Inorg Biochem 101(9):1275\u20131284","journal-title":"J Inorg Biochem"},{"key":"2174_CR67","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mcn.2017.07.002","volume":"83","author":"V Theendakara","year":"2017","unstructured":"Theendakara V, Bredesen DE, Rao RV (2017) Downregulation of protein phosphatase 2A by apolipoprotein E: implications for Alzheimer\u2019s disease. Mol Cell Neurosci 83:83\u201391","journal-title":"Mol Cell Neurosci"},{"issue":"3","key":"2174_CR68","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.neurobiolaging.2012.07.003","volume":"34","author":"Y Xiong","year":"2013","unstructured":"Xiong Y, Jing XP, Zhou XW, Wang XL, Yang Y, Sun XY, Qiu M, Cao FY et al (2013) Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation. Neurobiol Aging 34(3):745\u2013756","journal-title":"Neurobiol Aging"},{"issue":"2","key":"2174_CR69","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuint.2011.05.010","volume":"59","author":"L Martin","year":"2012","unstructured":"Martin L, Page G, Terro F (2012) Tau phosphorylation and neuronal apoptosis induced by the blockade of PP2A preferentially involve GSK3beta. Neurochem Int 59(2):235\u2013250","journal-title":"Neurochem Int"},{"issue":"40","key":"2174_CR70","doi-asserted-by":"crossref","first-page":"27677","DOI":"10.1074\/jbc.M114.565358","volume":"289","author":"M Arif","year":"2014","unstructured":"Arif M, Wei J, Zhang Q, Liu F, Basurto-Islas G, Grundke-Iqbal I, Iqbal K (2014) Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of tau. J Biol Chem 289(40):27677\u201327691","journal-title":"J Biol Chem"},{"issue":"2\u20133","key":"2174_CR71","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbadis.2004.08.014","volume":"1739","author":"LI Binder","year":"2005","unstructured":"Binder LI, Guillozet-Bongaarts AL, Garcia-Sierra F, Berry RW (2005) Tau, tangles, and Alzheimer\u2019s disease. Biochim Biophys Acta 1739(2\u20133):216\u2013223","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"2174_CR72","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/jnc.12761","volume":"130","author":"DJ Luo","year":"2014","unstructured":"Luo DJ, Feng Q, Wang ZH, Sun DS, Wang Q, Wang JZ, Liu GP (2014) Knockdown of phosphotyrosyl phosphatase activator induces apoptosis via mitochondrial pathway and the attenuation by simultaneous tau hyperphosphorylation. J Neurochem 130(6):816\u2013825","journal-title":"J Neurochem"},{"key":"2174_CR73","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/2051-5960-1-82","volume":"1","author":"NA Hoffmann","year":"2013","unstructured":"Hoffmann NA, Dorostkar MM, Blumenstock S, Goedert M, Herms J (2013) Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice. Acta Neuropathol Commun 1:82","journal-title":"Acta Neuropathol Commun"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02174-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-020-02174-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02174-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T20:55:28Z","timestamp":1634936128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-020-02174-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["2174"],"URL":"https:\/\/doi.org\/10.1007\/s12035-020-02174-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,23]]},"assertion":[{"value":"18 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}